Analytical Data
-
Gene name
TSPAN1
- Application
-
Alternative Names
NET-1; Tetraspanin TM4-C; Tetraspan NET-1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
O60635
-
Expression Region
Thr112~Val215
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TSPAN1, or tetraspanin 1, is a member of the tetraspanin family, which is characterized by four transmembrane domains and is implicated in various cellular processes, including cell adhesion, migration, and signaling. Its role in cancer progression and metastasis has garnered significant interest, as TSPAN1 has been associated with the regulation of cancer cell behavior and the tumor microenvironment. Studies show that TSPAN1 enhances the invasive capabilities of cancer cells and is linked to poor prognosis in several malignancies. Its involvement in immune response modulation also suggests potential implications for therapeutic strategies targeting TSPAN1. Given its diverse functions and importance in disease, researchers are pursuing recombinant protein studies to elucidate TSPAN1's mechanisms of action, investigate its interactions with other proteins, and assess its potential as a biomarker or therapeutic target in cancer treatment. The production of TSPAN1 as a recombinant protein provides opportunities for in-depth structural and functional analyses, paving the way for novel interventions in oncology and immunotherapy.
